Houth Therapeutics ISIN: US44148G2049 Forum: Aktien User: 00000

👀

😃

https://www.ad-hoc-news.de/boerse/news/ueberblick/hoth-therapeutics-aktie-vom-biotech-zum-weltraum-konzern/69426578

👀

👁

..

Hoth Therapeutics (NASDAQ: HOTH) received a positive regulatory conclusion under the EU Clinical Trials Information System (CTIS) for Part I of its HT-001 oncology program targeting EGFR inhibitor–related dermatologic toxicities. The CTIS determination confirms scientific and regulatory acceptability of the trial design and investigational products and gives a clear line of sight to site activation and enrollment across multiple European countries. Country-specific Part II decisions in Hungary, Spain, and Poland are expected by January 19, 2026. Hoth expects near-term site activation, patient enrollment, and advancement into active clinical execution for this supportive-care oncology study.

Hallo, über welche Broker lässt sich die Aktie handeln? Auf Trade Republic leider nicht zu finden..